Chonluten

Chonluten

Chonluten (EDG) is a short peptide bioregulator that modulates gene expression tied to inflammation, antioxidant defense, and cellular proliferation—particularly within lung tissue. Research positions it as both a geroprotective agent and an anti-inflammatory tool for respiratory and gastrointestinal studies.

Solution Peptides

Chonluten exerts its strongest regulatory effects in lung tissue, with secondary activity in the gastrointestinal tract. By normalizing bronchial mucosal function and tempering inflammatory gene expression, it has attracted interest for chronic lung diseases such as asthma and COPD.

Chonluten (Glu–Asp–Gly) is a short bioregulatory tripeptide discussed in the context of bronchopulmonary tissue research and inflammatory signaling in monocyte/macrophage models. Because short peptides like this are described as having poor oral stability, the referenced protocol uses a once-daily subcutaneous approach. Educational context only.

Reconstitution Target (20 mg vial): Add 3.0 mL bacteriostatic water → 6.67 mg/mL.
Easy Measuring (U-100): 1 unit = 0.01 mL ≈ 66.67 mcg.

Dosing Schedule (3.0 mL → 6.67 mg/mL):
Route & Frequency: Inject once daily via the subcutaneous route. Rotate sites for comfort/consistency. For ≤10 unit (≤0.10 mL) administrations during Weeks 1–4, consider 30- or 50-unit insulin syringes for improved readability.

WeekDaily DoseInjection Volume
Weeks 1–2250 mcg (0.25 mg)3.75 units (0.0375 mL)
Weeks 3–4500 mcg (0.5 mg)7.5 units (0.075 mL)
Weeks 5–61,000 mcg (1 mg)15 units (0.15 mL)
Weeks 7–81,500 mcg (1.5 mg)22.5 units (0.225 mL)
Weeks 9–102,000 mcg (2 mg)30 units (0.30 mL)
Weeks 11–123,000 mcg (3 mg)45 units (0.45 mL)
Weeks 13–144,000 mcg (4 mg)60 units (0.60 mL)
Weeks 15–164,000 mcg (4 mg)60 units (0.60 mL)

Reconstitution Steps:
• Draw 3.0 mL bacteriostatic water with a sterile syringe.
• Inject slowly down the vial wall to minimize foaming.
• Gently swirl/roll until dissolved (do not shake).
• Label and refrigerate at 2–8 °C, protected from light.
• Avoid repeated freeze–thaw cycles.

Storage (as described):
Lyophilized (short-term): Refrigerate ~4 °C (dry, dark).
Lyophilized (long-term): Freeze at −20 °C (or colder).
Reconstituted: Refrigerate at 2–8 °C; avoid freeze–thaw. Allow vial to reach room temperature before opening to reduce condensation.

Important: This guide is for educational purposes only and is not medical advice. For research use only. Not for human consumption.

Sequence: Glu-Asp-Gly (EDG)

Molecular Formula: C11H17N3O8

Molecular Weight: 319.27 g/mol

PubChem CID: 194641

CAS Number: 75007-24-8

Synonyms: T-34 tripeptide, EDG

Short peptides—including di-, tri-, and tetrapeptides—have been shown in animal studies to extend lifespan by up to 40% and suppress tumor development. Computational and laboratory data indicate that these peptides can cross nuclear membranes and bind promoter regions to regulate DNA transcription.

Work by Dr. Vladimir Khavinson at the St. Petersburg Institute of Bioregulation and Gerontology highlights Chonluten’s ability to normalize gene expression patterns associated with aging, lending support to its classification as a geroprotective molecule.

Chonluten modulates genes such as c-Fos, HSP70, SOD, COX-2, and TNF-α to normalize bronchial mucosal function. These actions may counteract the structural and inflammatory changes observed in asthma and COPD, restoring mucus balance and extracellular matrix integrity.

Its stress-protective effects and ability to maintain performance in hypoxic conditions have also spurred interest in supportive roles during respiratory infections, including COVID-19 scenarios.

Preliminary research suggests Chonluten exerts similar, albeit milder, regulatory effects in the gastrointestinal tract. Investigations are underway to determine whether its anti-inflammatory gene modulation can translate to benefits in Crohn’s disease, ulcerative colitis, and other GI inflammatory disorders.

Chonluten is a short peptide that modulates genes tied to inflammation, antioxidant defense, and cellular proliferation—particularly in lung tissue. Its geroprotective profile, minimal reported side effects, and favorable subcutaneous bioavailability in mice make it a compelling candidate for further respiratory and anti-aging research.

PubMed

Article Author :

The above literature was researched, edited and organized by Dr. Logan, M.D. Dr. Logan holds a doctorate degree from https://case.edu/medicine/Case Western Reserve University School of Medicine and a B.S. in molecular biology.

Case Western Reserve University School of Medicine

ALL ARTICLES AND PRODUCT INFORMATION PROVIDED ON THIS WEBSITE ARE FOR INFORMATIONAL AND EDUCATIONAL PURPOSES ONLY.

The product information featured on this website pertains exclusively to in-vitro studies. In-vitro studies, also known as ‘in glass’ studies, are conducted outside of living organisms. It’s important to emphasize that these products do not constitute medicines or drugs and have not received FDA approval for the prevention, treatment, or cure of any medical conditions, ailments, or diseases. It is crucial to note that the introduction of these products into the bodies of humans or animals is strictly prohibited by law.

PRODUCT USAGE

THIS PRODUCT IS INTENDED AS A RESEARCH CHEMICAL ONLY. This designation allows the use of research chemicals strictly for in vitro testing and laboratory experimentation only. All product information available on this website is for educational purposes only. Bodily introduction of any kind into humans or animals is strictly forbidden by law. This product should only be handled by licensed, qualified professionals. This product is not a drug, food, or cosmetic and may not be misbranded, misused or mislabled as a drug, food or cosmetic.